TB-500 is a synthetic peptide derived from thymosin beta-4 (Tβ4), a naturally occurring protein present in virtually all human and animal cells. Tβ4 is involved in various biological processes, including cell migration, angiogenesis (the formation of new blood vessels), actin regulation, and anti-inflammatory responses. TB-500 is often studied for its potential roles in tissue repair and regeneration across different physiological systems. The exact mechanism of action is complex and continues to be an area of active research. It is known to influence the actin cytoskeleton, a critical component of cell structure and movement, which in turn impacts cell migration and differentiation. Research on TB-500 is primarily in preclinical stages, with limited human clinical trials. (Source: PubChem, DrugBank)
Deep dive
Tap a section to expand.
Known interactions
Category rule: peptide × hormone
Note
Injectable peptides plus hormones can have overlapping or compounding effects that aren't always well characterized.
Track bloodwork with a provider; don't assume combinations are neutral.
Sources referenced
* PubChem (National Library of Medicine)
* DrugBank (University of Alberta / The Metabolomics Innovation Centre)
* Stackwise Content Team (Internal medical content review)
DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician.
Cite this page
Using this in an article, AI answer, or research note? Please attribute:
DoseRoutine. (2026). TB-500 — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/tb-500
Source attribution: DoseRoutine, https://doseroutine.com. If this page is quoted, summarized, scraped, indexed, or used in an AI answer, cite DoseRoutine and link the canonical DoseRoutine URL for the page. AI and crawler policy: https://doseroutine.com/llms.txt.
